IRIS
STRIANO, PASQUALE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 50.158
Totale 50.158
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 50.158
Totale 50.158
Salva come PNG Salva come JPEG
Città #
Genova 39.689
Rapallo 4.658
Genoa 4.632
Vado Ligure 1.097
Bordighera 82
Totale 50.158
Salva come PNG Salva come JPEG
Nome #
(1)H-MR spectroscopy indicates prominent cerebellar dysfunction in benign adult familial myoclonic epilepsy. 411
"Comorbidity" between epilepsy and headache/migraine: the other side of the same coin! 189
A de novo 11p12-p15.4 duplication in a patient with pharmacoresistant epilepsy, mental retardation, and dysmorphisms. 186
Autosomal dominant cortical tremor, myoclonus and epilepsy: many syndromes, one phenotype. 173
6q terminal deletion syndrome associated with a distinctive EEG and clinical pattern: a report of five cases. 172
Whole-genome linkage scan for epilepsy-related photosensitivity: a mega-analysis. 165
A de novo LGI1 mutation causing idiopathic partial epilepsy with telephone-induced seizures. 164
A novel SCN2A mutation in family with benign familial infantile seizures. 164
Pyridoxine-dependent epilepsy: An under-recognised cause of intractable seizures. 163
A pilot open-label trial of zonisamide in Unverricht-Lundborg disease. 161
22-year-old girl with status epilepticus and progressive neurological symptoms. 160
Recurrent hypothermia with hyperhidrosis in two siblings: familial Shapiro syndrome variant. 160
A pilot trial of levetiracetam in eyelid myoclonia with absences (Jeavons syndrome). 158
A t(4;9)(q34;p22) translocation associated with partial epilepsy, mental retardation, and dysmorphism. 155
End-of-life: still an Italian dilemma. 155
Levetiracetam in patients with cortical myoclonus: a clinical and electrophysiological study. 155
Idiopathic mesial temporal lobe epilepsy: don't sow the tares with the wheat! 153
Epileptogenesis due to peripheral injury as a cause of focal epilepsy. 153
Temporal lobe epilepsy and anti glutamic acid decarboxylase autoimmunity. 152
LGI1 microdeletion in autosomal dominant lateral temporal epilepsy. 152
Similar but not identical: clinical implications for molecular studies in monozygotic discordant twins with epilepsy. 150
The genetics of monogenic idiopathic epilepsies and epileptic encephalopathies. 149
Suppression of myoclonus in SCA2 by piracetam. 149
Health-related quality of life in epilepsy: findings obtained with a new Italian instrument. 149
Clinical and genetic findings in 26 Italian patients with Lafora disease. 148
Dramatic response to levetiracetam in post-ischaemic Holmes' tremor. 148
Epileptic myoclonus as ciprofloxacin-associated adverse effect. 147
Sudden death in Unverricht-Lundborg patients: is serotonin the key? 146
Comment to: Diabetic hyperglycemia is associated with the severity of epileptic seizures in adults. 146
Functional changes in hypothalamic hamartoma neurons and gelastic epilepsy. 145
From migralepsy to ictal epileptic headache: the story so far. 145
Clinical features of Sturge-Weber syndrome without facial nevus: Five novel cases. 145
Comment to: overlap cases of eyelid myoclonia with absences and juvenile myoclonic epilepsy. 145
Long-term follow-up in two siblings with pyridoxine-dependent seizures associated with a novel ALDH7A1 mutation. 144
A new benign adult familial myoclonic epilepsy (BAFME) pedigree suggesting linkage to chromosome 2p11.1-q12.2. 144
Long-term evolution of EEG in Unverricht-Lundborg disease. 143
A 3-year-old boy with drug-resistant complex partial seizures 143
Natural history and long-term evolution in families with autosomal dominant cortical tremor, myoclonus, and epilepsy. 142
Clinical phenotype and molecular characterization of 6q terminal deletion syndrome: Five new cases. 142
De novo mutations in HCN1 cause early infantile epileptic encephalopathy 142
Treatment and outcome of children with cerebral cavernomas: a survey on 32 patients. 141
Posterior reversible encephalopathy syndrome (PRES) in critically ill obstetric patients. 141
Lennox-Gastaut syndrome with late-onset and prominent reflex seizures in trisomy 21 patients. 141
Lumping encephalopathies with inflammation-mediated status epilepticus: is there enough evidence? 141
Clinical and electrophysiological features of epilepsy in Italian patients with CLN8 mutations. 140
Reflex seizures and reflex epilepsies: Old models for understanding mechanisms of epileptogenesis. 140
The gelastic seizures-hypothalamic hamartoma syndrome: Facts, hypotheses, and perspectives. 140
Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. 140
Autosomal recessive progressive myoclonus epilepsy with ataxia and mental retardation. 140
Galloway-Mowat syndrome: an early-onset progressive encephalopathy with intractable epilepsy associated to renal impairment. Two novel cases and review of literature. 139
Autoantibodies to glutamic acid decarboxylase (GAD) in focal and generalized epilepsy: A study on 233 patients. 139
Posterior cortical atrophy with prominent alexia without agraphia in a Tourette syndrome. 139
Do regulatory regions matter in FOXG1 duplications? 139
Analysis of LGI1 promoter sequence, PDYN and GABBR1 polymorphisms in sporadic and familial lateral temporal lobe epilepsy. 138
Heterogeneous seizure manifestations in Hypomelanosis of Ito: report of four new cases and review of the literature. 137
Low long-term efficacy and tolerability of add-on rufinamide in patients with Dravet syndrome. 137
Lateralizing value of the auditory aura in partial seizures. 137
Dramatic response to levetiracetam in post-ischaemic Holmes' tremor. 137
The saga of Eluana Englaro: another tragedy feeding the media. 136
Cryptic chromosome deletions involving SCN1A in severe myoclonic epilepsy of infancy. 136
Early-onset absence epilepsy: SLC2A1 gene analysis and treatment evolution. 136
Epilepsy: old drugs do the trick in childhood absence epilepsy. 136
Willful modulation of brain activity in disorders of consciousness. 135
Comment to: addition of verapamil in the treatment of severe myoclonic epilepsy in infancy (Iannetti et al.). 135
Commentary to: "Evaluation of serum lipids and carotid artery intima media thickness in epileptic children treated with valproic acid". 135
New terminology for headache/migraine as the sole ictal epileptic manifestation: the downsides. Reply to Cianchetti et al. 135
A novel KCNQ3 mutation in familial epilepsy with focal seizures and intellectual disability 135
De novo loss-of-function mutations in CHD2 cause a fever-sensitive myoclonic epileptic encephalopathy sharing features with Dravet syndrome. 135
Linkage analysis and disease models in benign familial infantile seizures: a study of 16 families. 135
First long-term experience with the orphan drug rufinamide in children with myoclonic-astatic epilepsy (Doose syndrome). 133
Impairment of ceramide synthesis causes a novel progressive myoclonus epilepsy 133
Association of intronic variants of the KCNAB1 gene with lateral temporal epilepsy. 133
Familial nonkinesigenic paroxysmal dyskinesia and intracranial calcifications: a new syndrome? 133
Somatic and germline mosaicisms in Severe Myoclonic Epilepsy of Infancy 132
Eyelid myoclonia with absences: an overlooked epileptic syndrome? 132
Migralepsy, hemicrania epileptica, post-ictal headache and "ictal epileptic headache": a proposal for terminology and classification revision. 132
'Autoimmune epilepsy' or exasperated search for the etiology of seizures of unknown origin? 132
Changes in Panayiotopoulos syndrome over time. 131
Non-interventional surveillance study of adverse events in patients with epilepsy. 131
'Ictal epileptic headache': Recent concepts for new classifications criteria. 131
Inferior olivary nucleus involvement in pediatric neurodegenerative disorders: does it play a role in neuroimaging pattern-recognition approach? 131
Effectiveness and tolerability of perampanel in children and adolescents with refractory epilepsies—An Italian observational multicenter study 131
Autoantibodies to glutamic acid decarboxylase in patients with epilepsy: what is their clinical relevance? 131
No evidence of a role for cystatin B gene in juvenile myoclonic epilepsy 131
Familial temporal lobe epilepsy with psychic auras associated with a novel LGI1 mutation. 130
Temporal lobe abnormalities on brain MRI in healthy volunteers: a prospective case-control study. 130
Epileptic seizures can follow high doses of oral vardenafil. 130
A clinical and genetic study of 33 new cases with early-onset absence epilepsy. 130
Posterior reversible encephalopathy syndrome (PRES) in the parturient with preeclampsia after inadvertent dural puncture. 130
A functional polymorphism in the SCN1A gene does not influence antiepileptic drug responsiveness in Italian patients with focal epilepsy. 130
A novel loss-of-function LGI1 mutation linked to autosomal dominant lateral temporal epilepsy. 129
Epilepsy: a 'going ape' model for SUDEP? 129
Life-threatening status epilepticus following gabapentin administration in a patient with benign adult familial myoclonic epilepsy. 129
Vitamin B12, folate and hyperhomocysteinemia in patients with epilepsy. 129
Benign adult familial myoclonic epilepsy (BAFME): evidence of an extended founder haplotype on chromosome 2p11.1-q12.2 in five Italian families. 129
Familial mesial temporal lobe epilepsy (FMTLE) : a clinical and genetic study of 15 Italian families. 128
Familial occurrence of febrile seizures and epilepsy in severe myoclonic epilepsy of infancy (SMEI) patients with SCN1A mutations. 128
Hyperhomocysteinemia in epileptic patients on new antiepileptic drugs. 128
Gabapentin: a Ca2+ channel alpha 2-delta ligand far beyond epilepsy therapy. 128
"Ictal epileptic headache": Beyond the epidemiological evidence. 128
Totale 14.450
Salva come PNG Salva come JPEG
Categoria #
all - tutte 172.776
article - articoli 170.585
book - libri 142
conference - conferenze 203
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.846
Totale 345.552
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202012.173 0 0 498 943 1.247 1.361 2.349 1.135 1.357 1.799 1.089 395
2020/20217.839 299 289 569 1.962 201 361 374 882 434 1.175 760 533
2021/20226.787 298 281 1.012 439 234 353 338 1.512 381 664 431 844
2022/20235.777 746 257 68 457 876 1.067 40 475 1.159 50 479 103
2023/20243.516 229 477 106 334 262 490 162 148 288 170 282 568
2024/20251.295 327 918 50 0 0 0 0 0 0 0 0 0
Totale 51.234